Cerity Partners LLC Adma Biologics, Inc. Transaction History
Cerity Partners LLC
- $44.7 Billion
- Q3 2024
A detailed history of Cerity Partners LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 50,878 shares of ADMA stock, worth $973,296. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,878
Previous 20,241
151.36%
Holding current value
$973,296
Previous $226,000
350.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ADMA
# of Institutions
318Shares Held
184MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$357 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$347 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$249 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$241 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$165 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.76B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...